---
$id: https://graph.org.ai/products/commodity/51111870
$type: Product
source: UNSPSC
code: "51111870"
title: "Vapreotide"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Vapreotide

**UNSPSC Code**: 51111870
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a somatostatin receptor agonist with the molecular formula C57H70N12O9S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2PK59M9GFF, chemically known as l-tryptophanamide, d-phenylalanyl-l-cysteinyl-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl-l-cysteinyl-, cyclic (2->7)-disulfide but generally known as vapreotide, which bears US NIH Compound Identifier 71306. European Medicines Agency schedules Vapreotide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00026MIG. The term VAPREOTIDE is an International Non-Proprietary Name. World Health Organization schedules vapreotide in its Anatomical Therapeutic Chemical (ATC) Classification. VAPREOTIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule vapreotide under HS 29349990 and SITC 51579. As of Q4 2014, VAPREOTIDE remains the US FDA Preferred Term for this commodity. Vapreotide bears US NLM identifiers UMLS ID C0164678 and NCI Concept Code C1429. SMILES: S1SCC(NC(=O)C(N)CC2CCCCC2)C(=O)NC(C(=O)NC(CC2C3C([NH]C2)CCCC3)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(C1)C(=O)NC(CC1C2C([NH]C1)CCCC2)C(=O)N)CC1CCC(O)CC1.

